Structural basis of a public antibody response to SARS-CoV-2

Molecular-level understanding of human neutralizing antibody responses to SARS-CoV-2 could accelerate vaccine design and facilitate drug discovery. We analyzed 294 SARS-CoV-2 antibodies and found that IGHV3-53 is the most frequently used IGHV gene for targeting the receptor binding domain (RBD) of the spike (S) protein. We determined crystal structures of two IGHV3-53 neutralizing antibodies +/- Fab CR3022 ranging from 2.33- to 3.11-angstrom resolution. The germline-encoded residues of IGHV3-53 dominate binding to the ACE2 binding site epitope with no overlap with the CR3022 epitope. Moreover, IGHV3-53 is used in combination with a very short CDR H3 and different light chains. Overall, IGHV3-53 represents a versatile public VH in neutralizing SARS-CoV-2 antibodies, where their specific germline features and minimal affinity maturation provide important insights for vaccine design and assessing outcomes. ### Competing Interest Statement The authors have declared no competing interest.

Download data

• Downloaded 1,763 times
• Download rankings, all-time:
  • Site-wide: 7,301 out of 118,977
  • In microbiology: 386 out of 9,394
• Year to date:
  • Site-wide: 3,108 out of 118,977
• Since beginning of last month:
  • Site-wide: 15,060 out of 118,977

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide